We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Stabilization Platform Assists Endolumenal Interventions

By HospiMedica International staff writers
Posted on 15 May 2018
Image: An endoscopic accessory stabilizes endoluminal procedures (Photo courtesy of Lumendi).
Image: An endoscopic accessory stabilizes endoluminal procedures (Photo courtesy of Lumendi).
A novel accessory ensures complete positioning of an endoscope in the large intestine and assists with optical visualization, diagnosis, and treatment.

The Lumendi (High Wycombe, United Kingdom) DiLumen C2 is an endolumenal interventional platform that consists of a soft flexible sheath that fits over standard and small diameter endoscopes. The device employs two balloons, one behind the bending section of the endoscope and the second in front of the tip. When both balloons are deployed and inflated, the area in between the two balloons is stabilized, creating a therapeutic zone that facilitates stabilization, insufflation, and manipulation of the tissue, thus allowing the clinician to more effectively treat the target area.

The platform also includes two six mm diameter tool channels, which accommodate two independent flexible articulating hand instruments, such as a flexible grasper called the DiLumen Ig, which can be used together with the DiLumen C2 to grasp and manipulate mucosal tissue. Several additional flexible articulating instruments are under development, and will be available for cutting and dissection of tissue. Once the therapy is completed the balloons are simply deflated and removed, along with the colonoscope.

“We are continuing our commitment to develop innovative devices that facilitate endolumenal procedures for many gastrointestinal interventions in an effort to reduce costs and improve patient outcomes,” said Dr. Peter Johann, CEO of Lumendi. “To date, we have completed over 350 procedures with the commercially available DiLumen EIP, with no serious adverse events.”

Related Links:
Lumendi
Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Mammography System (Analog)
MAM VENUS

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more